{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:11:29Z","timestamp":1780456289422,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13000-015-0254-8","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T17:10:26Z","timestamp":1427994626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Accumulation of invariant NKT cells with increased IFN-\u03b3 production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia"],"prefix":"10.1186","volume":"10","author":[{"given":"Ting","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"254_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"254_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/mi.2008.33","volume":"1","author":"A Kobayashi","year":"2008","unstructured":"Kobayashi A, Weinberg V, Darragh T, Smith-McCune K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008;1:412\u201320.","journal-title":"Mucosal Immunol"},{"key":"254_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1086\/320190","volume":"183","author":"AM Solares","year":"2001","unstructured":"Solares AM, Baladron I, Ramos T, Valenzuela C, Borbon Z, Fanjull S, et al. Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial. J Infect Dis. 2001;183:1485\u201393.","journal-title":"J Infect Dis"},{"key":"254_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, De Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327.","journal-title":"N Engl J Med"},{"key":"254_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244\u201365.","journal-title":"J Clin Pathol"},{"key":"254_CR6","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1158\/1078-0432.CCR-06-0114","volume":"12","author":"S Motohashi","year":"2006","unstructured":"Motohashi S, Ishikawa A, Ishikawa E, Otsuji M, Iizasa T, Hanaoka H, et al. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res. 2006;12:6079\u201386.","journal-title":"Clin Cancer Res"},{"key":"254_CR7","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.4049\/jimmunol.170.3.1430","volume":"170","author":"B Grubor-Bauk","year":"2003","unstructured":"Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V\u03b114-J\u03b1281 TCR. J Immunol. 2003;170:1430\u20134.","journal-title":"J Immunol"},{"key":"254_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1054\/bjoc.2001.1973","volume":"85","author":"A Kikuchi","year":"2001","unstructured":"Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, et al. In vitro anti-tumour activity of \u03b1-galactosylceramide-stimulated human invariant V\u03b124\u2009+\u2009NKT cells against melanoma. Br J Cancer. 2001;85:741\u20136.","journal-title":"Br J Cancer"},{"key":"254_CR9","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.4049\/jimmunol.172.10.5908","volume":"172","author":"M Falcone","year":"2004","unstructured":"Falcone M, Facciotti F, Ghidoli N, Monti P, Olivieri S, Zaccagnino L, et al. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immol. 2004;172:5908\u201316.","journal-title":"J Immol"},{"key":"254_CR10","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.4049\/jimmunol.168.12.6007","volume":"168","author":"LT Mars","year":"2002","unstructured":"Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, et al. V\u03b114-J\u03b1281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immol. 2002;168:6007\u201311.","journal-title":"J Immol"},{"key":"254_CR11","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/j.1600-6143.2007.01827.x","volume":"7","author":"X Jiang","year":"2007","unstructured":"Jiang X, Koji S, Harada M, Ohkohchi N, Taniguchi M, Seino KI. Mechanism of NKT cell-mediated transplant tolerance. Am J Transplant. 2007;7:1482\u201390.","journal-title":"Am J Transplant"},{"key":"254_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/TP.0b013e318187265e","volume":"86","author":"T Onzuka","year":"2008","unstructured":"Onzuka T, Tomita Y, Shimizu I, Okano S, Yamada H, Yoshikai Y, et al. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance. Transplantation. 2008;86:1301\u201310.","journal-title":"Transplantation"},{"key":"254_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1349-7006.2008.00730.x","volume":"99","author":"S Motohashi","year":"2008","unstructured":"Motohashi S, Nakayama T. Clinical applications of natural killer T cell-based immunotherapy for cancer. Cancer Sci. 2008;99:638\u201345.","journal-title":"Cancer Sci"},{"key":"254_CR14","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.4049\/jimmunol.0902191","volume":"184","author":"SR Mattarollo","year":"2010","unstructured":"Mattarollo SR, Rahimpour A, Choyce A, Godfrey DI, Leggatt GR, Frazer IH. Invariant NKT cells in hyperplastic skin induced a local immune suppressive environment by IFN-\u03b3 production. J Immunol. 2010;184:1242\u201350.","journal-title":"J Immunol"},{"key":"254_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0008-6363(03)00362-6","volume":"60","author":"A Yndestad","year":"2003","unstructured":"Yndestad A, Holm AM, M\u00fcller F, Simonsen S, Fr\u00f8land SS, Gullestad L, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res. 2003;60:101\u20136.","journal-title":"Cardiovasc Res"},{"key":"254_CR16","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1200\/JCO.2005.02.568","volume":"23","author":"DL Kienle","year":"2005","unstructured":"Kienle DL, Korz C, Hosch B, Benner A, Mertens D, Habermann A, et al. Evidence for distinct pathomechanisms in Genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J Clin Oncol. 2005;23:3780\u201392.","journal-title":"J Clin Oncol"},{"key":"254_CR17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/hc3901.096721","volume":"104","author":"Z Mallat","year":"2001","unstructured":"Mallat Z, Corbaz A, Scoazec A, Besnard S, Les\u00e8che G, Chvatchko Y, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001;104:1598\u2013603.","journal-title":"Circulation"},{"key":"254_CR18","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1002\/cncr.24411","volume":"115","author":"Y Carrero","year":"2009","unstructured":"Carrero Y, Callejas D, Ala\u00f1a F, Silva C, Mindiola R, Mosquera J. Increased vascular endothelial growth factor expression, CD3-positive cell infiltration, and oxidative stress in premalignant lesions of the cervix. Cancer. 2009;115:3680\u20138.","journal-title":"Cancer"},{"key":"254_CR19","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.4049\/jimmunol.167.7.4046","volume":"167","author":"SM Tahir","year":"2001","unstructured":"Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, Wilson SB, et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol. 2001;167:4046\u201350.","journal-title":"J Immunol"},{"key":"254_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ijc.20998","volume":"116","author":"JW Molling","year":"2005","unstructured":"Molling JW, K\u00f6lgen W, van der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg CH, et al. Peripheral blood IFN-\u03b3-secreting V\u03b124+V\u03b211+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer. 2005;116:87\u201393.","journal-title":"Int J Cancer"},{"key":"254_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GY Ho","year":"1998","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423\u20138.","journal-title":"N Engl J Med"},{"key":"254_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1086\/317638","volume":"183","author":"KL Liaw","year":"2001","unstructured":"Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183:8\u201315.","journal-title":"J Infect Dis"},{"key":"254_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/OLQ.0b013e318164e567","volume":"35","author":"J Monsonego","year":"2008","unstructured":"Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Zerat L, et al. Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests. Sex Transm Dis. 2008;35:521\u20137.","journal-title":"Sex Transm Dis"},{"key":"254_CR24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jmv.21515","volume":"81","author":"MP Stevens","year":"2009","unstructured":"Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, Tabrizi SN. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol. 2009;81:1283\u20139121.","journal-title":"J Med Virol"},{"key":"254_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-065X.2010.00966.x","volume":"239","author":"P Bhat","year":"2011","unstructured":"Bhat P, Mattarollo SR, Gosmann C, Frazer IH, Leggatt GR. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev. 2011;239:85\u201398.","journal-title":"Immunol Rev"},{"key":"254_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00404-008-0621-8","volume":"278","author":"PJ Maluf","year":"2008","unstructured":"Maluf PJ, Michelin MA, Etchebehere RM, Adad SJ, Murta EF. T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III. Arch Gynecol Obstet. 2008;278:525\u201330.","journal-title":"Arch Gynecol Obstet"},{"key":"254_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297\u2013336.","journal-title":"Annu Rev Immunol"},{"key":"254_CR28","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1128\/JVI.01053-10","volume":"84","author":"S Miura","year":"2010","unstructured":"Miura S, Kawana K, Schust DJ, Fujii T, Yokoyama T, Iwasawa Y, et al. CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV. J Virol. 2010;84:11614\u201323.","journal-title":"J Virol"},{"key":"254_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4049\/jimmunol.177.2.769","volume":"177","author":"RR Brutkiewicz","year":"2006","unstructured":"Brutkiewicz RR. CD1d ligands: the good, the bad and the ugly. J Immuol. 2006;177:769\u201375.","journal-title":"J Immuol"},{"key":"254_CR30","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-05-0877","volume":"11","author":"T Tachibana","year":"2005","unstructured":"Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, et al. Increased intratumor V\u03b124-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res. 2005;11:7322\u20137.","journal-title":"Clin Cancer Res"},{"key":"254_CR31","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.4049\/jimmunol.168.12.6494","volume":"168","author":"K Yanagisawa","year":"2002","unstructured":"Yanagisawa K, Seino K, Ishikawa Y, Nozue M, Todoroki T, Fukao K. Impaired proliferative response of V\u03b124 NKTcells from cancer patients against \u03b1-galactosylceramide. J Immunol. 2002;168:6494\u20139.","journal-title":"J Immunol"},{"key":"254_CR32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/ijc.22894","volume":"121","author":"JW Molling","year":"2007","unstructured":"Molling JW, De Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, et al. CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer. 2007;121:1749\u201355.","journal-title":"Int J Cancer"},{"key":"254_CR33","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20022227","volume":"198","author":"M Terabe","year":"2003","unstructured":"Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, et al. Transforming growth factor-\u03b2 production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med. 2003;198:1741\u201352.","journal-title":"J Exp Med"},{"key":"254_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ijc.20669","volume":"114","author":"JM Park","year":"2005","unstructured":"Park JM, Terabe M, van den Broeke LT, Donaldson DD, Berzofsky JA. Unmasking immunosurveillance against a syngenic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13. Int J Cancer. 2005;114:80\u20137.","journal-title":"Int J Cancer"},{"key":"254_CR35","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1002\/ijc.21764","volume":"118","author":"GJ Renukaradhya","year":"2006","unstructured":"Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Van Kaer L, Brutkiewicz RR. Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo. Int J Cancer. 2006;118:3045\u201353.","journal-title":"Int J Cancer"},{"key":"254_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1479-5876-7-108","volume":"7","author":"SH van der Burg","year":"2009","unstructured":"van der Burg SH, Palefsky JM. Human immunodeficiency virus and human papilloma virus-why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med. 2009;7:108.","journal-title":"J Transl Med"},{"key":"254_CR37","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00262-008-0495-4","volume":"57","author":"JA Berzofsky","year":"2008","unstructured":"Berzofsky JA, Terabe M. A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity. Cancer Immunol Immunother. 2008;57:1679\u201383.","journal-title":"Cancer Immunol Immunother"},{"key":"254_CR38","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.4049\/jimmunol.179.8.5126","volume":"179","author":"E Ambrosino","year":"2007","unstructured":"Ambrosino E, Terabe M, Halder RC, Peng J, Takaku S, Miyake S, et al. Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J Immunol. 2007;179:5126\u201336.","journal-title":"J Immunol"},{"key":"254_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/intimm\/dxh020","volume":"16","author":"S Kobayshi","year":"2004","unstructured":"Kobayshi S, Kaneko Y, Seino K, Yamada Y, Motohashi S, Koike J, et al. Impaired IFN-\u03b3 production of V\u03b124 NKT cells in non-remitting sarcoidosis. Int Immunol. 2004;16:215\u201322.","journal-title":"Int Immunol"},{"key":"254_CR40","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.4049\/jimmunol.0800681","volume":"182","author":"S Pastor","year":"2009","unstructured":"Pastor S, Minguela A, Mi W, Ward ES. Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-\u03b3 in regulating susceptibility to experimental autoimmune encephalomyelitis. J Immunol. 2009;182:5268\u201375.","journal-title":"J Immunol"},{"key":"254_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4049\/jimmunol.178.1.134","volume":"178","author":"A Minguela","year":"2007","unstructured":"Minguela A, Pastor S, Mi W, Richardson JA, Ward ES. Feedback regulation of murine autoimmunity via dominant anti-inflammatory effects of interferon \u03b3. J Immunol. 2007;178:134\u201344.","journal-title":"J Immunol"},{"key":"254_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2567.2011.03477.x","volume":"134","author":"L Zhao","year":"2011","unstructured":"Zhao L, Gao XL, Peng Y, Joyee AG, Bai H, Wang SH, et al. Differential modulating effect of natural killer (NK) T cells on interferon-\u03b3 production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection. Immunology. 2011;134:172\u201384.","journal-title":"Immunology"},{"key":"254_CR43","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/ijc.23733","volume":"123","author":"S Textor","year":"2008","unstructured":"Textor S, D\u00fcrst M, Jansen L, Accardi R, Tommasino M, Trunk MJ, et al. Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer. 2008;123:2343\u201353.","journal-title":"Int J Cancer"},{"key":"254_CR44","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.4049\/jimmunol.0903730","volume":"184","author":"SR Mattarollo","year":"2010","unstructured":"Mattarollo SR, Yong M, Tan L, Franzer IH, Leggatt GR. Secretion of IFN-\u03b3 but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen. J Immunol. 2010;184:5663\u20139.","journal-title":"J Immunol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-015-0254-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-015-0254-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-015-0254-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-015-0254-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:59:13Z","timestamp":1630576753000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-015-0254-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1186\/s13000-015-0254-8","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]},"assertion":[{"value":"26 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}